Snibe attained outstanding results across all 9 biochemistry routine assays and 18 concentration levels in this assessment with a 100% pass rate. This achievement further validates the accuracy of Snibe’s biochemical assays and our robust capability in metrological traceability.

Philips has recently partnered with six companies to expand its capabilities in wearable devices and out‑of‑hospital patient monitoring.